Evolution Capital Management LLC E Ffector Therapeutics, Inc. Call Options Transaction History

Evolution Capital Management LLC

  • $21.8 Million
  • Q4 2022

Call Options

0 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
No transaction found.

Others Institutions Holding EFTR

# of Institutions
5
Shares Held
6.46M
Call Options Held
0
Put Options Held
0
View Full List

About eFFECTOR Therapeutics, Inc.

EFTR Quotes by TradingView
  • Ticker EFTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 41,452,800
  • Description
  • eFFECTOR Therapeutics, Inc., a clinical-stage biopharmaceutical company, engages in the development of selective translation regulator inhibitors for the treatment of cancer. Its lead product candidate is Tomivosertib, an oral small-molecule inhibitor of MNK that is in phase 2b clinical trial for the treatment of patients with metastatic non-sma...
More about EFTR
Track This Portfolio

Track Evolution Capital Management LLC Portfolio

Follow Evolution Capital Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Evolution Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Evolution Capital Management LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email